News

Toxys wins BioBusiness Masterclass Award 2015

- Gisteren sleepte Toxys de BioBusiness Masterclass Award 2015 in de wacht tijdens het HollandBIO Dutch Life Sciences SME Event. Het bedrijf, een spin-off van het Leids Universitair Medisch Centrum (LUMC), ontwikkelde de ToxTracker test. Deze in vitro assay van Toxys is gebaseerd op embryonale stamcellen en maakt het mogelijk om verschillende kankerverwekkende effecten van stoffen op een eenvoudige en betrouwbare manier te identificeren.

Rotterdam Eye Hospital participates on Experiment TopCare

- Om de gecombineerde functie van topreferente zorg, onderzoek, opleiding en onderwijs te ondersteunen neemt Het Oogziekenhuis Rotterdam deel aan het vierjarige experiment TopZorg van het ministerie van VWS.

Questions & Answers on Product Development Partnerships III Fund

- On 22 May 2015 an information meeting took place at the Netherlands Enterprise Agency in the Hague. Around 40 people from different organizations attended. Here you will find the questions and answers from the meeting on Friday May 22nd and the conference call on Tuesday May 26th 2015

Winners of the Bio Art & Design Award 2015

- De Bio Art & Design (BAD) Award 2015 gaat naar de Microbioom Veiligheidsdienst (Emma Conley, Ierland), Drones met een Drang (Agi Haines, Groot-Brittannië) en De Kunst der Misleiding (Isaac Monté, België). Deze drie kunstprojecten rondom biotechnologie, ieder goed voor 25.000 euro, zijn vrijdag 22 mei door een internationale jury uitgeroepen tot winnaars. Bij de uitvoering van elk BAD Award-project is een Nederlandse biowetenschapper nauw betrokken.

Rockstart launches accelerator for digital health startups

- Rockstart launches its first accelerator program for digital health startups, aiming to make a sustainable impact on global health systems. Working with an extensive network of mentors and investors, as well as key health institutions and organizations, the Nijmegen-based program helps startups get access to the healthcare system itself. This allows them to engage directly with patients, professionals and other stakeholders to validate their product or service. The program runs from September, applications are now open (from May 20) and can be submitted at www.rockstart.com.

FICHe showcases 40 startups during eHealthWeek in Riga

- From May 11 to 13 the FICHe project joined the eHealthWeek event in Riga. Together with the 40 startups and SMEs that are selected for the second phase of the FICHe accelerator program, the FICHe project team is showcasing the results of the first part of the project. Six Dutch startups and SMEs are currently part of the project.

Health~Holland Update, May 2015

- We are happy to present to you the second edition of our bimonthly news magazine, the Health~Holland Update.

Product Development Partnerships III Fund

- The Product Development Partnerships III Fund (PDP III) contributes to innovation in the areas of healthcare products and technologies specifically aimed at diseases and conditions related to poverty and sexual and reproductive health and rights (SRHR).

Pfizer Acquires Minority Interest in AM-Pharma; Secures Option to Acquire Company

- AM‐Pharma B.V., a privately held Dutch biopharmaceutical company focused on the development of recombinant human Alkaline Phosphatase (recAP ) for inflammatory diseases, and Pfizer Inc. (NYSE: PFE) announced today that Pfizer has acquired a minority equity interest in AM-Pharma and secured an exclusive option to acquire the remaining equity in the company.

MorphoSys Acquires Peptide Therapeutic Company Lanthio Pharma

- Acquisition Adds Novel Candidates Including Pre-IND Candidate for Fibrotic Diseases to MorphoSys’s Growing Proprietary Portfolio.